Lymphoproliferative disease and acquired C1 inhibitor deficiency
* Division of Internal Medicine, Department of Internal Medicine and Medical Specialities IRCCS Fondazione Ospedale Maggiore Policlinico of Milan, Milan, Italy ° Clinica Ematologia, TMO Università degli Studi di Milano, Bicocca Ospedale San Gerardo di Monza; II Division of Internal Medicine, Sacco H...
Saved in:
Published in | Haematologica (Roma) Vol. 92; no. 5; pp. 716 - 718 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
Italy
Ferrata Storti Foundation
01.05.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | * Division of Internal Medicine, Department of Internal Medicine and Medical Specialities IRCCS Fondazione Ospedale Maggiore Policlinico of Milan, Milan, Italy
° Clinica Ematologia, TMO Università degli Studi di Milano, Bicocca Ospedale San Gerardo di Monza; II Division of Internal Medicine, Sacco Hospital, University of Milan, Italy
Correspondence: Roberto Castelli, MD, Department of Internal Medicine and Medical Specialities, IRCCS Fondazione Ospedale Maggiore Policlinico of Milan, via Pace 9, 20122 Milan, Italy. Phone: international +39.02.55035320. Fax: international +39.02.55034722. E-mail: castelli39{at}interfree.it
Angioedema due to acquired deficiency of the C1-inhibitor is a bridging condition between autoimmunity and lymphoproliferation. We report 32 patients with acquired C1 inhibitor deficiency: 23 have anti C1-inhibitor autoantibodies; 13 have monoclonal gammopathies of unknown significance and 9 have non-Hodgkins lymphoma. Our series suggest that different forms of B cell disorders coexist and/or evolve into each other in acquired angioedema.
Key words: C1 inhibitor, deficiency, acquired, lymphoproliferative, autoantibody. |
---|---|
Bibliography: | SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 |
ISSN: | 0390-6078 1592-8721 |
DOI: | 10.3324/haematol.10769 |